Articles From: The Journal of Clinical Endocrinology & Metabolism Publishes Radius Health's Phase II Study of the Investigational Drug Abaloparatide in Postmenopausal Women With Osteoporosis to The Manitowoc Company to Present at Deutsche Bank Leveraged Finance Conference


2014/11/24
-- Multi-center, multi-national, double-blind, placebo-controlled trial in which postmenopausal women were randomized to receive 24-weeks of treatment with either daily subcutaneous injections of placebo, the investigational drug abaloparatide 20, 40 or 80-μg, or teriparatide 20-μg.
Sign-up for The Journal of Clinical Endocrinology & Metabolism Publishes Radius Health's Phase II Study of the Investigational Drug Abaloparatide in Postmenopausal Women With Osteoporosis investment picks
2014/12/12
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0983912001&sourceType=1 http://media3.marketwire.com/logos/20141110-KEGST.jpg VANCOUVER, BRITISH COLUMBIA --
Sign-up for The Keg Royalties Income Fund Announces December 2014 Cash Distribution investment picks
2014/11/13
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0978918001&sourceType=1 http://media3.marketwire.com/logos/20141110-KEGST.jpg VANCOUVER, BRITISH COLUMBIA --
Sign-up for The Keg Royalties Income Fund Announces November 2014 Cash Distribution investment picks
2014/10/10
-- The Fifth Anniversary of The Knot Gala Will Bring Together the Wedding Industry's A-Listers for One Night Only, Featuring a Live Stream Red-Carpet Show on TheKnot.com -- NEW YORK , Oct.
Sign-up for The Knot, The #1 Brand In Weddings, Live-Streams Bridal Fashion Week, Giving An Inside Look To Brides Around The World investment picks
2014/10/20
The Korea Fund, Inc. (NYSE:KF) announced today a portfolio manager call as part of the next Annual Meeting of Stockholders, to be held at 10:30 a.m., Eastern time, on October 30, 2014.
Sign-up for The Korea Fund, Inc. Announces Portfolio Manager Conference Call investment picks
2014/10/27
The Korea Fund, Inc. (NYSE:KF) (the “Fund”) announced today that a Portfolio Management Presentation for the reporting period ending September 30, 2014, which contains updated fund performance, portfolio characteristics, top holdings, market outlook, portfolio strategy, and fund statistics, is now available as literature at www.thekoreafund.com .
Sign-up for The Korea Fund, Inc. Posts Portfolio Management Presentation investment picks
2014/10/30
The Korea Fund, Inc. (NYSE:KF) (the “Fund”) announced today that an updated Portfolio Management Presentation for the reporting period ending September 30, 2014, which contains fund performance, portfolio characteristics, top holdings, market outlook, portfolio strategy, and fund statistics, is now available as literature at www.thekoreafund.com .
Sign-up for The Korea Fund, Inc. Posts Updated Portfolio Management Presentation investment picks
2014/11/28
The Korea Fund, Inc. (the "Fund") (NYSE: KF), a non-diversified, closed-end investment company, which seeks long-term capital appreciation through investment in securities, primarily equity securities, of Korean companies, today announced its results for the fiscal quarter ended September 30, 2014.
Sign-up for The Korea Fund, Inc. Reports Results for the Fiscal Quarter Ended September 30, 2014 investment picks
2014/11/3
The Board of Directors of The Korea Fund, Inc. (the “Fund”) (NYSE:KF), today announced a change to the measurement period for the Fund’s share repurchase program to align it with the Fund’s June 30 fiscal year end.
Sign-up for The Korea Fund, Inc. Revises Measurement Period for Share Repurchase Program investment picks
2014/11/25
Reports Record Fiscal 2014 Earnings, Closes Alagasco Purchase ST.
Sign-up for The Laclede Group Completes Successful Year of Growth investment picks
2014/11/20
Dividend Grows for 12th Consecutive Year ST.
Sign-up for The Laclede Group Raises Dividend by 4.5 Percent investment picks
2014/11/13
ST. LOUIS , Nov.
Sign-up for The Laclede Group to Host Earnings Conference Call on November 25 investment picks
Prana Biotechnology (ASX:PBT)(NASDAQ:PRAN) has today announced the results of its Phase 2 trial in Huntington Disease, REACH2HD, has been published online in one of the world’s leading medical journals, The Lancet Neurology .
Sign-up for The Lancet Neurology Publishes Prana's Huntington Disease Trial investment picks
Data From Phase 3 RUTHERFORD-2 Study Show Evolocumab Significantly Reduced Mean LDL-C by 59-66 Percent Compared to Placebo in Patients With Heterozygous Familial Hypercholesterolemia Phase 3 TESLA Data Show Evolocumab Significantly Reduced LDL-C by 31 Percent Compared to Placebo in Patients With Homozygous Familial Hypercholesterolemia THOUSAND OAKS, Calif.
Sign-up for The Lancet Publishes Two Phase 3 Studies Showing Cholesterol-Lowering Medication Evolocumab Significantly Reduced LDL Cholesterol In Patients With Serious Genetic Disorders That Cause High Cholesterol investment picks
2014/12/3
The Loss of Robin Williams, Buzz About the New iPhone, and the Rise of Jennifer Lawrence Top Yahoo Canada's Year in Review 2014 Canada NewsWire The Annual Review Highlights the Top Stories and Newsmakers That Fascinated Canadians TORONTO , Dec.
Sign-up for The Loss of Robin Williams, Buzz About the New iPhone, and the Rise of Jennifer Lawrence Top Yahoo Canada's Year in Review 2014 investment picks
As part of a multi-million dollar investment to restore Europe’s most iconic hotels under The Luxury Collection, Starwood Hotels & Resorts Worldwide, Inc. (NYSE:HOT) today unveiled the restored public spaces at Hotel Imperial, a Luxury Collection Hotel, Vienna .
Sign-up for The Luxury Collection Celebrates the 140th Anniversary of Hotel Imperial in Vienna, Following a Meticulous Year-Long Restoration investment picks
The Luxury Collection Hotels & Resorts, part of Starwood Hotels & Resorts, Inc. (NYSE:HOT), unveils its latest collaboration with Assouline: Epicurean Journeys , a hardcover collection of original recipes by renowned chefs, including: Chef Jose Andres, Geoffrey Zakarian, Stephanie Le Quellec, Daniele Turco, Manjit Gill and more.
Sign-up for The Luxury Collection Hotels & Resorts Celebrates Spice with Chefs from around the World in New Assouline Book, Epicurean Journeys investment picks
Would Separate Live Entertainment Businesses from Sports and Media Businesses to Create Two Distinct Public Companies NEW YORK, Oct.
Sign-up for The Madison Square Garden Company Board of Directors Unanimously Approves Plan to Explore Possible Spin-Off investment picks
Sale of the Fuse Network Successfully Completed on July 1, 2014 Company Exploring Possible Separation of Its Businesses Into Two Distinct Public Companies Board of Directors Authorized Repurchase of Up to $500 Million of Class A Common Stock NEW YORK, Oct.
Sign-up for The Madison Square Garden Company Reports Fiscal 2015 First Quarter Results investment picks
2014/12/5
Digital Shorts Bring Famed Scottish Distilleries Into the Spotlight with the Help of a Fully Grown Human Being NEW YORK , Dec.
Sign-up for The Makers of Oban® and Lagavulin® Release My Tales of Whisky investment picks
The Manitowoc Company, Inc. (NYSE: MTW) today reported sales of $986.3 million for the third quarter of 2014, a decrease of 2.5 percent compared to sales of $1.012 billion in the third quarter of 2013.
Sign-up for The Manitowoc Company Reports Third-quarter Financial Results investment picks
The Manitowoc Company, Inc. (NYSE: MTW) announced today that it will release its third-quarter 2014 financial results on Monday, October 27, after the close of market.
Sign-up for The Manitowoc Company Schedules Third-quarter 2014 Earnings Announcement and Conference Call investment picks
The Manitowoc Company, Inc. (NYSE: MTW) today announced that it will participate in the Credit Suisse Global Industrial Conference, which will be held at the Credit Suisse Conference Center in New York, NY.
Sign-up for The Manitowoc Company to Present at Credit Suisse Global Industrial Conference investment picks
The Manitowoc Company, Inc. (NYSE: MTW) today announced that it will participate in the 22 nd Annual Deutsche Bank Leveraged Finance Conference, which will be held at The Phoenician Hotel in Scottsdale, Arizona.
Sign-up for The Manitowoc Company to Present at Deutsche Bank Leveraged Finance Conference investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: The Journal of Clinical Endocrinology & Metabolism Publishes Radius Health's Phase II Study of the Investigational Drug Abaloparatide in Postmenopausal Women With Osteoporosis to The Manitowoc Company to Present at Deutsche Bank Leveraged Finance Conference
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent